Arlin Za
- Hematology top 2%
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 6
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
-
- Acute Lymphoblastic Leukemia research 10
- Oncology top 10%
- Cancer Treatment and Pharmacology 5
- Neutropenia and Cancer Infections 3
-
- Cancer therapeutics and mechanisms 3
-
- T-cell and Retrovirus Studies 2
- Co-authors
- DC Jr CaseWiernik PhBD ClarksonSanford KempinBenjamín KozinerSusan McKenziePaul BaskindAbraham Mittelman
- Journals
- Blood (10 papers)Journal of Clinical Oncology (1 paper)PubMed (17 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Arlin Za
27 papers receiving 876 citations
Peers
Comparison fields: 5 of 56
- Hematology 627
- Genetics 202
- Public Health, Environmental and Occupational Health 381
- Oncology 307
- Pathology and Forensic Medicine 111
Countries citing papers authored by Arlin Za
This map shows the geographic impact of Arlin Za's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlin Za with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlin Za more than expected).
Fields of papers citing papers by Arlin Za
This network shows the impact of papers produced by Arlin Za. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlin Za. The network helps show where Arlin Za may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arlin Za, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 22 | |
| 2 | Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia. | 1991 | 20 |
| 3 | Idarubicin in acute leukemia: an effective new therapy for the future. | 1989 | 6 |
| 4 | Mitoxantrone and amsacrine: two important agents for the treatment of acute myelogenous leukemia (AML) and acute lymphoblastic leukemia (ALL). | 1989 | 3 |
| 5 | 1989 | 4 | |
| 6 | Treatment of patients with advanced cancer using multiple long-term cultured lymphokine-activated killer (LAK) cell infusions and recombinant human interleukin-2. | 1989 | 11 |
| 7 | 1988 | 49 | |
| 8 | 1988 | 40 | |
| 9 | Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects. | 1988 | 1 |
| 10 | Autologous and allogeneic bone marrow transplantation. | 1986 | 8 |
| 11 | 1986 | 87 | |
| 12 | Phase I-II trial of mitoxantrone in acute leukemia. | 1985 | 45 |
| 13 | 1984 | 5 | |
| 14 | 1984 | 40 | |
| 15 | The treatment of acute nonlymphoblastic leukemia in adults. | 1983 | 3 |
| 16 | Current status of amsacrine (AMSA) combination chemotherapy programs in acute leukemia. | 1983 | 34 |
| 17 | Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. | 1982 | 21 |
| 18 | "Polymyositis"-like syndrome resulting from hypothyroidism in a patient with a nodular lymphoma. | 1981 | 3 |
| 19 | 1980 | 61 | |
| 20 | 1980 | 3 |
About Arlin Za
Arlin Za is a scholar working on Hematology, Genetics and Oncology, having authored 28 papers that have together received 925 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (10 papers), Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (3 papers), Neutropenia and Cancer Infections (3 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Hematology (627 citations), Genetics (202 citations) and Public Health, Environmental and Occupational Health (381 citations). Arlin Za has collaborated with scholars based in United States and Canada. Frequent co-authors include DC Jr Case, Wiernik Ph, BD Clarkson, Sanford Kempin, Benjamín Koziner, Susan McKenzie, Paul Baskind, Abraham Mittelman, Young Cw and Roland Mertelsmann. Their work appears in journals such as Blood, Journal of Clinical Oncology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.